Savior Lifetec Corporation (TPEX:4167)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.10
-0.20 (-1.04%)
Apr 28, 2026, 1:30 PM CST
4.66%
Market Cap 5.93B
Revenue (ttm) 1.20B
Net Income (ttm) 537.45M
Shares Out 310.44M
EPS (ttm) 1.71
PE Ratio 11.17
Forward PE n/a
Dividend 0.81 (4.17%)
Ex-Dividend Date Jul 14, 2025
Volume 725,739
Average Volume 1,071,908
Open 19.35
Previous Close 19.30
Day's Range 19.05 - 19.35
52-Week Range 16.45 - 22.60
Beta 0.19
RSI 36.19
Earnings Date May 7, 2026

About Savior Lifetec

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 384
Stock Exchange Taipei Exchange
Ticker Symbol 4167
Full Company Profile

Financial Performance

In 2025, Savior Lifetec's revenue was 1.20 billion, a decrease of -1.28% compared to the previous year's 1.22 billion. Earnings were 537.45 million, an increase of 194.69%.

Financial Statements

News

There is no news available yet.